nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PTGS2—glaucoma	0.318	1	CbGaD
Sulindac—SLC22A6—Methazolamide—glaucoma	0.0686	0.273	CbGbCtD
Sulindac—CYP1A1—Clonidine—glaucoma	0.0566	0.225	CbGbCtD
Sulindac—SLC22A6—Acetazolamide—glaucoma	0.0548	0.218	CbGbCtD
Sulindac—CYP1A2—Betaxolol—glaucoma	0.0461	0.183	CbGbCtD
Sulindac—CYP1A2—Clonidine—glaucoma	0.0253	0.101	CbGbCtD
Sulindac—MAPK3—optic choroid—glaucoma	0.0115	0.318	CbGeAlD
Sulindac—MAPK3—endothelium—glaucoma	0.00471	0.13	CbGeAlD
Sulindac—AKR1B1—eye—glaucoma	0.00319	0.0882	CbGeAlD
Sulindac—AKR1B1—retina—glaucoma	0.00316	0.0874	CbGeAlD
Sulindac—AKR1B1—connective tissue—glaucoma	0.00307	0.085	CbGeAlD
Sulindac—MAPK3—eye—glaucoma	0.00231	0.064	CbGeAlD
Sulindac—MAPK3—retina—glaucoma	0.00229	0.0634	CbGeAlD
Sulindac—MAPK3—connective tissue—glaucoma	0.00223	0.0616	CbGeAlD
Sulindac—PTGS1—endothelium—glaucoma	0.00128	0.0354	CbGeAlD
Sulindac—PTGS2—endothelium—glaucoma	0.00122	0.0339	CbGeAlD
Sulindac—PTGS1—connective tissue—glaucoma	0.000606	0.0167	CbGeAlD
Sulindac—PTGS2—connective tissue—glaucoma	0.000579	0.016	CbGeAlD
Sulindac—Nervousness—Clonidine—glaucoma	0.000235	0.000966	CcSEcCtD
Sulindac—Paraesthesia—Dorzolamide—glaucoma	0.000235	0.000966	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000234	0.000964	CcSEcCtD
Sulindac—Dyspnoea—Dorzolamide—glaucoma	0.000233	0.000959	CcSEcCtD
Sulindac—Visual impairment—Betaxolol—glaucoma	0.000233	0.000959	CcSEcCtD
Sulindac—Insomnia—Brinzolamide—glaucoma	0.000232	0.000957	CcSEcCtD
Sulindac—Somnolence—Dorzolamide—glaucoma	0.000232	0.000956	CcSEcCtD
Sulindac—Dyspnoea—Travoprost—glaucoma	0.000232	0.000955	CcSEcCtD
Sulindac—Hypotension—Pilocarpine—glaucoma	0.000231	0.00095	CcSEcCtD
Sulindac—Paraesthesia—Brinzolamide—glaucoma	0.000231	0.00095	CcSEcCtD
Sulindac—Dysuria—Timolol—glaucoma	0.000231	0.000949	CcSEcCtD
Sulindac—Dyspepsia—Dorzolamide—glaucoma	0.00023	0.000947	CcSEcCtD
Sulindac—Dyspnoea—Brinzolamide—glaucoma	0.000229	0.000943	CcSEcCtD
Sulindac—Dyspepsia—Travoprost—glaucoma	0.000229	0.000943	CcSEcCtD
Sulindac—Asthenia—Apraclonidine—glaucoma	0.000229	0.000941	CcSEcCtD
Sulindac—Somnolence—Brinzolamide—glaucoma	0.000228	0.00094	CcSEcCtD
Sulindac—Vision blurred—Clonidine—glaucoma	0.000228	0.000937	CcSEcCtD
Sulindac—Decreased appetite—Dorzolamide—glaucoma	0.000227	0.000935	CcSEcCtD
Sulindac—Urticaria—Acetazolamide—glaucoma	0.000227	0.000932	CcSEcCtD
Sulindac—Dyspepsia—Brinzolamide—glaucoma	0.000226	0.000931	CcSEcCtD
Sulindac—Pruritus—Apraclonidine—glaucoma	0.000226	0.000928	CcSEcCtD
Sulindac—Body temperature increased—Acetazolamide—glaucoma	0.000225	0.000928	CcSEcCtD
Sulindac—Fatigue—Dorzolamide—glaucoma	0.000225	0.000928	CcSEcCtD
Sulindac—Tinnitus—Betaxolol—glaucoma	0.000225	0.000928	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000225	0.000926	CcSEcCtD
Sulindac—Fatigue—Travoprost—glaucoma	0.000224	0.000924	CcSEcCtD
Sulindac—Flushing—Betaxolol—glaucoma	0.000224	0.000923	CcSEcCtD
Sulindac—Ill-defined disorder—Clonidine—glaucoma	0.000224	0.000923	CcSEcCtD
Sulindac—Insomnia—Pilocarpine—glaucoma	0.000223	0.000919	CcSEcCtD
Sulindac—Decreased appetite—Brinzolamide—glaucoma	0.000223	0.000919	CcSEcCtD
Sulindac—Constipation—Travoprost—glaucoma	0.000223	0.000916	CcSEcCtD
Sulindac—Hyperglycaemia—Timolol—glaucoma	0.000223	0.000916	CcSEcCtD
Sulindac—Paraesthesia—Pilocarpine—glaucoma	0.000222	0.000913	CcSEcCtD
Sulindac—Asthenia—Bimatoprost—glaucoma	0.000222	0.000913	CcSEcCtD
Sulindac—Fatigue—Brinzolamide—glaucoma	0.000222	0.000912	CcSEcCtD
Sulindac—Angioedema—Clonidine—glaucoma	0.000221	0.000909	CcSEcCtD
Sulindac—Dyspnoea—Pilocarpine—glaucoma	0.00022	0.000906	CcSEcCtD
Sulindac—Somnolence—Pilocarpine—glaucoma	0.00022	0.000904	CcSEcCtD
Sulindac—Depression—Timolol—glaucoma	0.000219	0.000903	CcSEcCtD
Sulindac—Pruritus—Bimatoprost—glaucoma	0.000219	0.0009	CcSEcCtD
Sulindac—Diarrhoea—Apraclonidine—glaucoma	0.000218	0.000898	CcSEcCtD
Sulindac—Malaise—Clonidine—glaucoma	0.000218	0.000897	CcSEcCtD
Sulindac—Dyspepsia—Pilocarpine—glaucoma	0.000217	0.000895	CcSEcCtD
Sulindac—Chills—Betaxolol—glaucoma	0.000217	0.000893	CcSEcCtD
Sulindac—Syncope—Clonidine—glaucoma	0.000217	0.000892	CcSEcCtD
Sulindac—Arrhythmia—Betaxolol—glaucoma	0.000216	0.000889	CcSEcCtD
Sulindac—Feeling abnormal—Dorzolamide—glaucoma	0.000215	0.000887	CcSEcCtD
Sulindac—Decreased appetite—Pilocarpine—glaucoma	0.000215	0.000884	CcSEcCtD
Sulindac—Feeling abnormal—Travoprost—glaucoma	0.000214	0.000883	CcSEcCtD
Sulindac—Conjunctivitis—Timolol—glaucoma	0.000214	0.00088	CcSEcCtD
Sulindac—Gastrointestinal pain—Dorzolamide—glaucoma	0.000214	0.00088	CcSEcCtD
Sulindac—Alopecia—Betaxolol—glaucoma	0.000214	0.000879	CcSEcCtD
Sulindac—Palpitations—Clonidine—glaucoma	0.000214	0.000879	CcSEcCtD
Sulindac—Gastrointestinal pain—Travoprost—glaucoma	0.000213	0.000876	CcSEcCtD
Sulindac—Loss of consciousness—Clonidine—glaucoma	0.000212	0.000874	CcSEcCtD
Sulindac—Feeling abnormal—Brinzolamide—glaucoma	0.000212	0.000872	CcSEcCtD
Sulindac—Constipation—Pilocarpine—glaucoma	0.000211	0.000869	CcSEcCtD
Sulindac—Sweating—Timolol—glaucoma	0.000211	0.000868	CcSEcCtD
Sulindac—Dizziness—Apraclonidine—glaucoma	0.000211	0.000868	CcSEcCtD
Sulindac—Urticaria—Dorzolamide—glaucoma	0.000208	0.000855	CcSEcCtD
Sulindac—Epistaxis—Timolol—glaucoma	0.000207	0.000854	CcSEcCtD
Sulindac—Body temperature increased—Dorzolamide—glaucoma	0.000207	0.000851	CcSEcCtD
Sulindac—Tension—Betaxolol—glaucoma	0.000206	0.00085	CcSEcCtD
Sulindac—Dysgeusia—Betaxolol—glaucoma	0.000206	0.000848	CcSEcCtD
Sulindac—Arthralgia—Clonidine—glaucoma	0.000206	0.000847	CcSEcCtD
Sulindac—Chest pain—Clonidine—glaucoma	0.000206	0.000847	CcSEcCtD
Sulindac—Agranulocytosis—Timolol—glaucoma	0.000205	0.000845	CcSEcCtD
Sulindac—Asthenia—Acetazolamide—glaucoma	0.000205	0.000842	CcSEcCtD
Sulindac—Dizziness—Bimatoprost—glaucoma	0.000204	0.000841	CcSEcCtD
Sulindac—Nervousness—Betaxolol—glaucoma	0.000204	0.000841	CcSEcCtD
Sulindac—Urticaria—Brinzolamide—glaucoma	0.000204	0.00084	CcSEcCtD
Sulindac—Feeling abnormal—Pilocarpine—glaucoma	0.000204	0.000838	CcSEcCtD
Sulindac—Discomfort—Clonidine—glaucoma	0.000203	0.000837	CcSEcCtD
Sulindac—Vomiting—Apraclonidine—glaucoma	0.000203	0.000834	CcSEcCtD
Sulindac—Gastrointestinal pain—Pilocarpine—glaucoma	0.000202	0.000831	CcSEcCtD
Sulindac—Hypersensitivity—Brimonidine—glaucoma	0.000202	0.00083	CcSEcCtD
Sulindac—Dermatitis—Apraclonidine—glaucoma	0.000201	0.000827	CcSEcCtD
Sulindac—Headache—Apraclonidine—glaucoma	0.0002	0.000822	CcSEcCtD
Sulindac—Vision blurred—Betaxolol—glaucoma	0.000198	0.000816	CcSEcCtD
Sulindac—Oedema—Clonidine—glaucoma	0.000197	0.000812	CcSEcCtD
Sulindac—Asthenia—Brimonidine—glaucoma	0.000196	0.000808	CcSEcCtD
Sulindac—Body temperature increased—Pilocarpine—glaucoma	0.000195	0.000804	CcSEcCtD
Sulindac—Ill-defined disorder—Betaxolol—glaucoma	0.000195	0.000804	CcSEcCtD
Sulindac—Diarrhoea—Acetazolamide—glaucoma	0.000195	0.000803	CcSEcCtD
Sulindac—Rash—Bimatoprost—glaucoma	0.000195	0.000802	CcSEcCtD
Sulindac—Dermatitis—Bimatoprost—glaucoma	0.000195	0.000801	CcSEcCtD
Sulindac—Anaemia—Betaxolol—glaucoma	0.000194	0.0008	CcSEcCtD
Sulindac—Shock—Clonidine—glaucoma	0.000194	0.000799	CcSEcCtD
Sulindac—Pruritus—Brimonidine—glaucoma	0.000194	0.000797	CcSEcCtD
Sulindac—Headache—Bimatoprost—glaucoma	0.000194	0.000797	CcSEcCtD
Sulindac—Thrombocytopenia—Clonidine—glaucoma	0.000193	0.000795	CcSEcCtD
Sulindac—Hypersensitivity—Dorzolamide—glaucoma	0.000193	0.000793	CcSEcCtD
Sulindac—Tachycardia—Clonidine—glaucoma	0.000193	0.000792	CcSEcCtD
Sulindac—Hypersensitivity—Travoprost—glaucoma	0.000192	0.000789	CcSEcCtD
Sulindac—Hyperhidrosis—Clonidine—glaucoma	0.000191	0.000785	CcSEcCtD
Sulindac—Visual impairment—Timolol—glaucoma	0.00019	0.000783	CcSEcCtD
Sulindac—Malaise—Betaxolol—glaucoma	0.00019	0.000781	CcSEcCtD
Sulindac—Nausea—Apraclonidine—glaucoma	0.000189	0.000779	CcSEcCtD
Sulindac—Hypersensitivity—Brinzolamide—glaucoma	0.000189	0.000779	CcSEcCtD
Sulindac—Vertigo—Betaxolol—glaucoma	0.000189	0.000778	CcSEcCtD
Sulindac—Syncope—Betaxolol—glaucoma	0.000189	0.000777	CcSEcCtD
Sulindac—Dizziness—Acetazolamide—glaucoma	0.000189	0.000776	CcSEcCtD
Sulindac—Anorexia—Clonidine—glaucoma	0.000188	0.000774	CcSEcCtD
Sulindac—Asthenia—Dorzolamide—glaucoma	0.000188	0.000772	CcSEcCtD
Sulindac—Asthenia—Travoprost—glaucoma	0.000187	0.000769	CcSEcCtD
Sulindac—Palpitations—Betaxolol—glaucoma	0.000186	0.000765	CcSEcCtD
Sulindac—Pruritus—Dorzolamide—glaucoma	0.000185	0.000761	CcSEcCtD
Sulindac—Loss of consciousness—Betaxolol—glaucoma	0.000185	0.000761	CcSEcCtD
Sulindac—Asthenia—Brinzolamide—glaucoma	0.000184	0.000759	CcSEcCtD
Sulindac—Hypotension—Clonidine—glaucoma	0.000184	0.000759	CcSEcCtD
Sulindac—Pruritus—Travoprost—glaucoma	0.000184	0.000758	CcSEcCtD
Sulindac—Tinnitus—Timolol—glaucoma	0.000184	0.000758	CcSEcCtD
Sulindac—Nausea—Bimatoprost—glaucoma	0.000184	0.000756	CcSEcCtD
Sulindac—Hypersensitivity—Pilocarpine—glaucoma	0.000182	0.000749	CcSEcCtD
Sulindac—Pruritus—Brinzolamide—glaucoma	0.000182	0.000748	CcSEcCtD
Sulindac—Vomiting—Acetazolamide—glaucoma	0.000181	0.000746	CcSEcCtD
Sulindac—Dizziness—Brimonidine—glaucoma	0.000181	0.000745	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Clonidine—glaucoma	0.00018	0.00074	CcSEcCtD
Sulindac—Myalgia—Betaxolol—glaucoma	0.000179	0.000737	CcSEcCtD
Sulindac—Chest pain—Betaxolol—glaucoma	0.000179	0.000737	CcSEcCtD
Sulindac—Arthralgia—Betaxolol—glaucoma	0.000179	0.000737	CcSEcCtD
Sulindac—Diarrhoea—Dorzolamide—glaucoma	0.000179	0.000736	CcSEcCtD
Sulindac—Headache—Acetazolamide—glaucoma	0.000179	0.000735	CcSEcCtD
Sulindac—Insomnia—Clonidine—glaucoma	0.000178	0.000734	CcSEcCtD
Sulindac—Diarrhoea—Travoprost—glaucoma	0.000178	0.000733	CcSEcCtD
Sulindac—Asthenia—Pilocarpine—glaucoma	0.000177	0.000729	CcSEcCtD
Sulindac—Paraesthesia—Clonidine—glaucoma	0.000177	0.000729	CcSEcCtD
Sulindac—Discomfort—Betaxolol—glaucoma	0.000177	0.000728	CcSEcCtD
Sulindac—Arrhythmia—Timolol—glaucoma	0.000176	0.000726	CcSEcCtD
Sulindac—Dyspnoea—Clonidine—glaucoma	0.000176	0.000724	CcSEcCtD
Sulindac—Diarrhoea—Brinzolamide—glaucoma	0.000176	0.000724	CcSEcCtD
Sulindac—Somnolence—Clonidine—glaucoma	0.000175	0.000722	CcSEcCtD
Sulindac—Pruritus—Pilocarpine—glaucoma	0.000175	0.000719	CcSEcCtD
Sulindac—Alopecia—Timolol—glaucoma	0.000175	0.000718	CcSEcCtD
Sulindac—Dizziness—Dorzolamide—glaucoma	0.000173	0.000711	CcSEcCtD
Sulindac—Rash—Brimonidine—glaucoma	0.000173	0.00071	CcSEcCtD
Sulindac—Dermatitis—Brimonidine—glaucoma	0.000172	0.00071	CcSEcCtD
Sulindac—Dizziness—Travoprost—glaucoma	0.000172	0.000708	CcSEcCtD
Sulindac—Oedema—Betaxolol—glaucoma	0.000172	0.000707	CcSEcCtD
Sulindac—Headache—Brimonidine—glaucoma	0.000171	0.000706	CcSEcCtD
Sulindac—Decreased appetite—Clonidine—glaucoma	0.000171	0.000706	CcSEcCtD
Sulindac—Fatigue—Clonidine—glaucoma	0.00017	0.0007	CcSEcCtD
Sulindac—Dizziness—Brinzolamide—glaucoma	0.00017	0.000699	CcSEcCtD
Sulindac—Nausea—Acetazolamide—glaucoma	0.000169	0.000697	CcSEcCtD
Sulindac—Diarrhoea—Pilocarpine—glaucoma	0.000169	0.000696	CcSEcCtD
Sulindac—Shock—Betaxolol—glaucoma	0.000169	0.000695	CcSEcCtD
Sulindac—Tension—Timolol—glaucoma	0.000169	0.000694	CcSEcCtD
Sulindac—Constipation—Clonidine—glaucoma	0.000169	0.000694	CcSEcCtD
Sulindac—Dysgeusia—Timolol—glaucoma	0.000168	0.000693	CcSEcCtD
Sulindac—Thrombocytopenia—Betaxolol—glaucoma	0.000168	0.000692	CcSEcCtD
Sulindac—Tachycardia—Betaxolol—glaucoma	0.000168	0.00069	CcSEcCtD
Sulindac—Nervousness—Timolol—glaucoma	0.000167	0.000687	CcSEcCtD
Sulindac—Vomiting—Dorzolamide—glaucoma	0.000166	0.000684	CcSEcCtD
Sulindac—Hyperhidrosis—Betaxolol—glaucoma	0.000166	0.000683	CcSEcCtD
Sulindac—Rash—Dorzolamide—glaucoma	0.000165	0.000678	CcSEcCtD
Sulindac—Dermatitis—Dorzolamide—glaucoma	0.000165	0.000678	CcSEcCtD
Sulindac—Rash—Travoprost—glaucoma	0.000164	0.000675	CcSEcCtD
Sulindac—Dermatitis—Travoprost—glaucoma	0.000164	0.000675	CcSEcCtD
Sulindac—Headache—Dorzolamide—glaucoma	0.000164	0.000674	CcSEcCtD
Sulindac—Anorexia—Betaxolol—glaucoma	0.000164	0.000674	CcSEcCtD
Sulindac—Vomiting—Brinzolamide—glaucoma	0.000163	0.000673	CcSEcCtD
Sulindac—Dizziness—Pilocarpine—glaucoma	0.000163	0.000672	CcSEcCtD
Sulindac—Headache—Travoprost—glaucoma	0.000163	0.000671	CcSEcCtD
Sulindac—Nausea—Brimonidine—glaucoma	0.000163	0.000669	CcSEcCtD
Sulindac—Feeling abnormal—Clonidine—glaucoma	0.000163	0.000669	CcSEcCtD
Sulindac—Rash—Brinzolamide—glaucoma	0.000162	0.000667	CcSEcCtD
Sulindac—Vision blurred—Timolol—glaucoma	0.000162	0.000667	CcSEcCtD
Sulindac—Dermatitis—Brinzolamide—glaucoma	0.000162	0.000666	CcSEcCtD
Sulindac—Gastrointestinal pain—Clonidine—glaucoma	0.000161	0.000664	CcSEcCtD
Sulindac—Headache—Brinzolamide—glaucoma	0.000161	0.000663	CcSEcCtD
Sulindac—Hypotension—Betaxolol—glaucoma	0.00016	0.00066	CcSEcCtD
Sulindac—Angioedema—Timolol—glaucoma	0.000157	0.000646	CcSEcCtD
Sulindac—Vomiting—Pilocarpine—glaucoma	0.000157	0.000646	CcSEcCtD
Sulindac—Urticaria—Clonidine—glaucoma	0.000157	0.000645	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000156	0.000644	CcSEcCtD
Sulindac—Body temperature increased—Clonidine—glaucoma	0.000156	0.000642	CcSEcCtD
Sulindac—Rash—Pilocarpine—glaucoma	0.000156	0.000641	CcSEcCtD
Sulindac—Dermatitis—Pilocarpine—glaucoma	0.000156	0.00064	CcSEcCtD
Sulindac—Insomnia—Betaxolol—glaucoma	0.000155	0.000639	CcSEcCtD
Sulindac—Nausea—Dorzolamide—glaucoma	0.000155	0.000639	CcSEcCtD
Sulindac—Headache—Pilocarpine—glaucoma	0.000155	0.000637	CcSEcCtD
Sulindac—Nausea—Travoprost—glaucoma	0.000155	0.000636	CcSEcCtD
Sulindac—Vertigo—Timolol—glaucoma	0.000154	0.000636	CcSEcCtD
Sulindac—Paraesthesia—Betaxolol—glaucoma	0.000154	0.000635	CcSEcCtD
Sulindac—Syncope—Timolol—glaucoma	0.000154	0.000634	CcSEcCtD
Sulindac—Dyspnoea—Betaxolol—glaucoma	0.000153	0.00063	CcSEcCtD
Sulindac—Nausea—Brinzolamide—glaucoma	0.000153	0.000628	CcSEcCtD
Sulindac—Palpitations—Timolol—glaucoma	0.000152	0.000625	CcSEcCtD
Sulindac—Dyspepsia—Betaxolol—glaucoma	0.000151	0.000622	CcSEcCtD
Sulindac—Loss of consciousness—Timolol—glaucoma	0.000151	0.000622	CcSEcCtD
Sulindac—Decreased appetite—Betaxolol—glaucoma	0.000149	0.000614	CcSEcCtD
Sulindac—Hypertension—Timolol—glaucoma	0.000148	0.000611	CcSEcCtD
Sulindac—Fatigue—Betaxolol—glaucoma	0.000148	0.000609	CcSEcCtD
Sulindac—Constipation—Betaxolol—glaucoma	0.000147	0.000604	CcSEcCtD
Sulindac—Nausea—Pilocarpine—glaucoma	0.000147	0.000604	CcSEcCtD
Sulindac—Myalgia—Timolol—glaucoma	0.000146	0.000602	CcSEcCtD
Sulindac—Chest pain—Timolol—glaucoma	0.000146	0.000602	CcSEcCtD
Sulindac—Arthralgia—Timolol—glaucoma	0.000146	0.000602	CcSEcCtD
Sulindac—Hypersensitivity—Clonidine—glaucoma	0.000145	0.000598	CcSEcCtD
Sulindac—Discomfort—Timolol—glaucoma	0.000145	0.000595	CcSEcCtD
Sulindac—Asthenia—Clonidine—glaucoma	0.000142	0.000582	CcSEcCtD
Sulindac—Feeling abnormal—Betaxolol—glaucoma	0.000142	0.000582	CcSEcCtD
Sulindac—Anaphylactic shock—Timolol—glaucoma	0.00014	0.000577	CcSEcCtD
Sulindac—Oedema—Timolol—glaucoma	0.00014	0.000577	CcSEcCtD
Sulindac—Pruritus—Clonidine—glaucoma	0.00014	0.000574	CcSEcCtD
Sulindac—Shock—Timolol—glaucoma	0.000138	0.000568	CcSEcCtD
Sulindac—Urticaria—Betaxolol—glaucoma	0.000136	0.000561	CcSEcCtD
Sulindac—Body temperature increased—Betaxolol—glaucoma	0.000136	0.000559	CcSEcCtD
Sulindac—Hyperhidrosis—Timolol—glaucoma	0.000136	0.000558	CcSEcCtD
Sulindac—Diarrhoea—Clonidine—glaucoma	0.000135	0.000555	CcSEcCtD
Sulindac—Anorexia—Timolol—glaucoma	0.000134	0.00055	CcSEcCtD
Sulindac—Hypotension—Timolol—glaucoma	0.000131	0.00054	CcSEcCtD
Sulindac—Dizziness—Clonidine—glaucoma	0.00013	0.000537	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Timolol—glaucoma	0.000128	0.000526	CcSEcCtD
Sulindac—Insomnia—Timolol—glaucoma	0.000127	0.000522	CcSEcCtD
Sulindac—Hypersensitivity—Betaxolol—glaucoma	0.000127	0.000521	CcSEcCtD
Sulindac—Paraesthesia—Timolol—glaucoma	0.000126	0.000518	CcSEcCtD
Sulindac—Vomiting—Clonidine—glaucoma	0.000125	0.000516	CcSEcCtD
Sulindac—Dyspnoea—Timolol—glaucoma	0.000125	0.000515	CcSEcCtD
Sulindac—Somnolence—Timolol—glaucoma	0.000125	0.000513	CcSEcCtD
Sulindac—Rash—Clonidine—glaucoma	0.000124	0.000512	CcSEcCtD
Sulindac—Dermatitis—Clonidine—glaucoma	0.000124	0.000511	CcSEcCtD
Sulindac—Headache—Clonidine—glaucoma	0.000124	0.000509	CcSEcCtD
Sulindac—Dyspepsia—Timolol—glaucoma	0.000123	0.000508	CcSEcCtD
Sulindac—Asthenia—Betaxolol—glaucoma	0.000123	0.000507	CcSEcCtD
Sulindac—Decreased appetite—Timolol—glaucoma	0.000122	0.000502	CcSEcCtD
Sulindac—Pruritus—Betaxolol—glaucoma	0.000122	0.0005	CcSEcCtD
Sulindac—Fatigue—Timolol—glaucoma	0.000121	0.000498	CcSEcCtD
Sulindac—Diarrhoea—Betaxolol—glaucoma	0.000118	0.000484	CcSEcCtD
Sulindac—Nausea—Clonidine—glaucoma	0.000117	0.000482	CcSEcCtD
Sulindac—Feeling abnormal—Timolol—glaucoma	0.000116	0.000476	CcSEcCtD
Sulindac—Gastrointestinal pain—Timolol—glaucoma	0.000115	0.000472	CcSEcCtD
Sulindac—Dizziness—Betaxolol—glaucoma	0.000114	0.000467	CcSEcCtD
Sulindac—Urticaria—Timolol—glaucoma	0.000111	0.000459	CcSEcCtD
Sulindac—Body temperature increased—Timolol—glaucoma	0.000111	0.000456	CcSEcCtD
Sulindac—Vomiting—Betaxolol—glaucoma	0.000109	0.000449	CcSEcCtD
Sulindac—Rash—Betaxolol—glaucoma	0.000108	0.000446	CcSEcCtD
Sulindac—Dermatitis—Betaxolol—glaucoma	0.000108	0.000445	CcSEcCtD
Sulindac—Headache—Betaxolol—glaucoma	0.000108	0.000443	CcSEcCtD
Sulindac—Hypersensitivity—Timolol—glaucoma	0.000103	0.000425	CcSEcCtD
Sulindac—Nausea—Betaxolol—glaucoma	0.000102	0.00042	CcSEcCtD
Sulindac—Asthenia—Timolol—glaucoma	0.000101	0.000414	CcSEcCtD
Sulindac—Pruritus—Timolol—glaucoma	9.93e-05	0.000409	CcSEcCtD
Sulindac—Diarrhoea—Timolol—glaucoma	9.6e-05	0.000395	CcSEcCtD
Sulindac—Dizziness—Timolol—glaucoma	9.28e-05	0.000382	CcSEcCtD
Sulindac—Vomiting—Timolol—glaucoma	8.92e-05	0.000367	CcSEcCtD
Sulindac—Rash—Timolol—glaucoma	8.85e-05	0.000364	CcSEcCtD
Sulindac—Dermatitis—Timolol—glaucoma	8.84e-05	0.000364	CcSEcCtD
Sulindac—Headache—Timolol—glaucoma	8.79e-05	0.000362	CcSEcCtD
Sulindac—Nausea—Timolol—glaucoma	8.33e-05	0.000343	CcSEcCtD
Sulindac—MAPK3—Immune System—C1QB—glaucoma	5.66e-05	0.000375	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—CDKN1B—glaucoma	5.65e-05	0.000374	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.53e-05	0.000367	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.52e-05	0.000366	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	5.49e-05	0.000364	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—TNF—glaucoma	5.46e-05	0.000361	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—OPN4—glaucoma	5.45e-05	0.000361	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—SOD1—glaucoma	5.3e-05	0.000351	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDKN2B—glaucoma	5.29e-05	0.00035	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CCND2—glaucoma	5.28e-05	0.000349	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	5.22e-05	0.000346	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NGF—glaucoma	5.22e-05	0.000346	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	5.21e-05	0.000345	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—CDKN2B—glaucoma	5.12e-05	0.000339	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—glaucoma	5.11e-05	0.000339	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	5.09e-05	0.000337	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—glaucoma	5.08e-05	0.000336	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HEYL—glaucoma	5.06e-05	0.000335	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TXN—glaucoma	5.05e-05	0.000334	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—C3—glaucoma	4.96e-05	0.000329	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	4.95e-05	0.000328	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTGFR—glaucoma	4.9e-05	0.000325	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.88e-05	0.000323	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	4.84e-05	0.00032	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	4.84e-05	0.00032	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—CDKN2A—glaucoma	4.82e-05	0.000319	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.78e-05	0.000316	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—CYP1B1—glaucoma	4.74e-05	0.000314	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDKN2B—glaucoma	4.73e-05	0.000313	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.72e-05	0.000313	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CYP1B1—glaucoma	4.72e-05	0.000313	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ABCA1—glaucoma	4.72e-05	0.000313	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	4.68e-05	0.00031	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—APOE—glaucoma	4.62e-05	0.000306	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.6e-05	0.000305	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CAV1—glaucoma	4.58e-05	0.000303	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CA1—glaucoma	4.54e-05	0.0003	CbGpPWpGaD
Sulindac—MAPK3—Disease—HDAC9—glaucoma	4.51e-05	0.000299	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NR3C1—glaucoma	4.49e-05	0.000298	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—MMP9—glaucoma	4.48e-05	0.000297	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP2—glaucoma	4.47e-05	0.000296	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—VEGFA—glaucoma	4.44e-05	0.000294	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TNF—glaucoma	4.44e-05	0.000294	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.43e-05	0.000294	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CTSA—glaucoma	4.39e-05	0.000291	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TNF—glaucoma	4.37e-05	0.000289	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	4.36e-05	0.000289	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FN1—glaucoma	4.36e-05	0.000289	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—BAD—glaucoma	4.3e-05	0.000285	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGFR1OP—glaucoma	4.3e-05	0.000285	CbGpPWpGaD
Sulindac—PTGS2—Disease—HEYL—glaucoma	4.3e-05	0.000285	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—CDKN1B—glaucoma	4.27e-05	0.000283	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	4.23e-05	0.00028	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—SMO—glaucoma	4.19e-05	0.000277	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CA5A—glaucoma	4.17e-05	0.000276	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NARFL—glaucoma	4.17e-05	0.000276	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CA2—glaucoma	4.15e-05	0.000275	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	4.15e-05	0.000275	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	4.15e-05	0.000275	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—VEGFA—glaucoma	4.09e-05	0.000271	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.05e-05	0.000269	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.05e-05	0.000269	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—MMP1—glaucoma	4.04e-05	0.000268	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—CDKN1B—glaucoma	4.01e-05	0.000265	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.94e-05	0.000261	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—glaucoma	3.91e-05	0.000259	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—CAV1—glaucoma	3.87e-05	0.000257	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—glaucoma	3.85e-05	0.000255	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RPTOR—glaucoma	3.84e-05	0.000254	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.79e-05	0.000251	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—C3—glaucoma	3.78e-05	0.000251	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GSTM1—glaucoma	3.77e-05	0.00025	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.74e-05	0.000248	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NCK2—glaucoma	3.72e-05	0.000246	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—FN1—glaucoma	3.69e-05	0.000244	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—BCL2L1—glaucoma	3.62e-05	0.00024	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CA1—glaucoma	3.6e-05	0.000239	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.57e-05	0.000237	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—VEGFA—glaucoma	3.55e-05	0.000235	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—glaucoma	3.55e-05	0.000235	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—glaucoma	3.53e-05	0.000234	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CTSA—glaucoma	3.49e-05	0.000231	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.48e-05	0.00023	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NOS3—glaucoma	3.46e-05	0.000229	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—glaucoma	3.45e-05	0.000228	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	3.44e-05	0.000228	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB2—glaucoma	3.36e-05	0.000223	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP9—glaucoma	3.36e-05	0.000222	CbGpPWpGaD
Sulindac—PPARD—Metabolism—MTHFR—glaucoma	3.34e-05	0.000221	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CA2—glaucoma	3.29e-05	0.000218	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.29e-05	0.000218	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—BAD—glaucoma	3.28e-05	0.000217	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.22e-05	0.000213	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.22e-05	0.000213	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CA1—glaucoma	3.2e-05	0.000212	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP2—glaucoma	3.19e-05	0.000211	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HDAC9—glaucoma	3.16e-05	0.000209	CbGpPWpGaD
Sulindac—PPARD—Metabolism—APOE—glaucoma	3.11e-05	0.000206	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CTSA—glaucoma	3.09e-05	0.000205	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CAV1—glaucoma	3.08e-05	0.000204	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—glaucoma	3.04e-05	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDKN2A—glaucoma	3.02e-05	0.0002	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—VEGFA—glaucoma	3.02e-05	0.0002	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CDKN1B—glaucoma	3e-05	0.000199	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS3—glaucoma	2.93e-05	0.000194	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CA2—glaucoma	2.92e-05	0.000194	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TXN—glaucoma	2.92e-05	0.000194	CbGpPWpGaD
Sulindac—ALB—Metabolism—CA1—glaucoma	2.91e-05	0.000193	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.86e-05	0.000189	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.86e-05	0.000189	CbGpPWpGaD
Sulindac—ALB—Metabolism—CTSA—glaucoma	2.82e-05	0.000187	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MMP9—glaucoma	2.78e-05	0.000184	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EDN1—glaucoma	2.76e-05	0.000183	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.74e-05	0.000181	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDKN2A—glaucoma	2.7e-05	0.000179	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—glaucoma	2.68e-05	0.000178	CbGpPWpGaD
Sulindac—PTGS2—Disease—HDAC9—glaucoma	2.68e-05	0.000178	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDKN1B—glaucoma	2.68e-05	0.000177	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.67e-05	0.000177	CbGpPWpGaD
Sulindac—ALB—Metabolism—CA2—glaucoma	2.66e-05	0.000177	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.64e-05	0.000175	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—CDKN2B—glaucoma	2.61e-05	0.000173	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.6e-05	0.000173	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.6e-05	0.000173	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SOD1—glaucoma	2.55e-05	0.000169	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1A—glaucoma	2.51e-05	0.000166	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—VEGFA—glaucoma	2.49e-05	0.000165	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SMO—glaucoma	2.47e-05	0.000164	CbGpPWpGaD
Sulindac—MAPK3—Disease—CDKN2B—glaucoma	2.43e-05	0.000161	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—C3—glaucoma	2.41e-05	0.00016	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP9—glaucoma	2.4e-05	0.000159	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDKN1B—glaucoma	2.39e-05	0.000159	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.35e-05	0.000155	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NOS3—glaucoma	2.33e-05	0.000154	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TXN—glaucoma	2.32e-05	0.000154	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NR3C1—glaucoma	2.29e-05	0.000152	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CDKN1B—glaucoma	2.28e-05	0.000151	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTT1—glaucoma	2.27e-05	0.00015	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NTRK2—glaucoma	2.26e-05	0.00015	CbGpPWpGaD
Sulindac—MAPK3—Immune System—C3—glaucoma	2.2e-05	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—VEGFA—glaucoma	2.15e-05	0.000143	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTGS2—glaucoma	2.13e-05	0.000141	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.12e-05	0.00014	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—VEGFA—glaucoma	2.11e-05	0.00014	CbGpPWpGaD
Sulindac—MAPK3—Immune System—BCL2L1—glaucoma	2.11e-05	0.00014	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.1e-05	0.000139	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.07e-05	0.000137	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TXN—glaucoma	2.06e-05	0.000136	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CA1—glaucoma	2.04e-05	0.000135	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTHFR—glaucoma	2.03e-05	0.000135	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CTSA—glaucoma	1.97e-05	0.000131	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.97e-05	0.000131	CbGpPWpGaD
Sulindac—ALB—Hemostasis—MMP1—glaucoma	1.94e-05	0.000129	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NGFR—glaucoma	1.94e-05	0.000129	CbGpPWpGaD
Sulindac—MAPK3—Immune System—BAD—glaucoma	1.91e-05	0.000127	CbGpPWpGaD
Sulindac—MAPK3—Disease—APOE—glaucoma	1.89e-05	0.000125	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—glaucoma	1.88e-05	0.000125	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.88e-05	0.000124	CbGpPWpGaD
Sulindac—ALB—Metabolism—TXN—glaucoma	1.88e-05	0.000124	CbGpPWpGaD
Sulindac—MAPK3—Disease—CAV1—glaucoma	1.88e-05	0.000124	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CAV1—glaucoma	1.86e-05	0.000123	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CA2—glaucoma	1.86e-05	0.000123	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.86e-05	0.000123	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—glaucoma	1.84e-05	0.000122	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NTRK1—glaucoma	1.84e-05	0.000122	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.83e-05	0.000121	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.82e-05	0.000121	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.82e-05	0.000121	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ABCA1—glaucoma	1.81e-05	0.00012	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP1B1—glaucoma	1.81e-05	0.00012	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTT1—glaucoma	1.8e-05	0.000119	CbGpPWpGaD
Sulindac—ALB—Hemostasis—FN1—glaucoma	1.77e-05	0.000118	CbGpPWpGaD
Sulindac—MAPK3—Disease—BAD—glaucoma	1.76e-05	0.000117	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.71e-05	0.000113	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CDKN2B—glaucoma	1.7e-05	0.000113	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.7e-05	0.000112	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EDN1—glaucoma	1.63e-05	0.000108	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTT1—glaucoma	1.6e-05	0.000106	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—glaucoma	1.59e-05	0.000106	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—glaucoma	1.51e-05	9.97e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NGF—glaucoma	1.5e-05	9.92e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTT1—glaucoma	1.46e-05	9.64e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTM1—glaucoma	1.44e-05	9.56e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CDKN2B—glaucoma	1.44e-05	9.56e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP1B1—glaucoma	1.43e-05	9.5e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ABCA1—glaucoma	1.43e-05	9.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—C3—glaucoma	1.42e-05	9.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—glaucoma	1.42e-05	9.4e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—glaucoma	1.41e-05	9.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDKN1B—glaucoma	1.33e-05	8.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOE—glaucoma	1.33e-05	8.78e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CAV1—glaucoma	1.31e-05	8.7e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TXN—glaucoma	1.31e-05	8.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—glaucoma	1.3e-05	8.59e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.29e-05	8.53e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—glaucoma	1.28e-05	8.45e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ABCA1—glaucoma	1.27e-05	8.43e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP1B1—glaucoma	1.27e-05	8.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FN1—glaucoma	1.25e-05	8.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—BAD—glaucoma	1.24e-05	8.18e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CDKN1B—glaucoma	1.23e-05	8.14e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—glaucoma	1.21e-05	8.01e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.2e-05	7.94e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOE—glaucoma	1.19e-05	7.87e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.19e-05	7.86e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CAV1—glaucoma	1.18e-05	7.8e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.17e-05	7.77e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP1B1—glaucoma	1.16e-05	7.68e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ABCA1—glaucoma	1.16e-05	7.68e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTM1—glaucoma	1.15e-05	7.59e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOE—glaucoma	1.13e-05	7.46e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CAV1—glaucoma	1.12e-05	7.39e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—BAD—glaucoma	1.05e-05	6.95e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTT1—glaucoma	1.02e-05	6.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTM1—glaucoma	1.02e-05	6.74e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—glaucoma	1.02e-05	6.73e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—glaucoma	1.01e-05	6.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—glaucoma	9.93e-06	6.58e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOE—glaucoma	9.43e-06	6.25e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CAV1—glaucoma	9.34e-06	6.19e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTM1—glaucoma	9.27e-06	6.14e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—glaucoma	8.99e-06	5.95e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—glaucoma	8.9e-06	5.89e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CDKN1B—glaucoma	8.6e-06	5.7e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—glaucoma	8.43e-06	5.59e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOE—glaucoma	8.37e-06	5.54e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CAV1—glaucoma	8.29e-06	5.49e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.21e-06	5.44e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—glaucoma	8.19e-06	5.43e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—glaucoma	8.14e-06	5.39e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ABCA1—glaucoma	8.11e-06	5.37e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP1B1—glaucoma	8.11e-06	5.37e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—glaucoma	7.97e-06	5.28e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—glaucoma	7.67e-06	5.08e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOE—glaucoma	7.63e-06	5.05e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CAV1—glaucoma	7.56e-06	5.01e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CDKN1B—glaucoma	7.31e-06	4.84e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—glaucoma	7.16e-06	4.74e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—glaucoma	7.06e-06	4.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTM1—glaucoma	6.48e-06	4.3e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—glaucoma	6.27e-06	4.15e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—glaucoma	5.73e-06	3.8e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—glaucoma	5.73e-06	3.8e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—glaucoma	5.71e-06	3.79e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—glaucoma	5.41e-06	3.58e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOE—glaucoma	5.34e-06	3.53e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CAV1—glaucoma	5.29e-06	3.5e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—glaucoma	5.23e-06	3.46e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—glaucoma	4e-06	2.65e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—glaucoma	3.66e-06	2.42e-05	CbGpPWpGaD
